Coastal Corp reports strong Q2 FY26 profit growth, considers subsidiary merger
Coastal Corporation Limited reported significant profit growth for Q2 FY26 in both standalone and consolidated results and is considering a merger of two wholly-owned subsidiaries.
The announcement includes the release of quarterly financial results showing strong profit growth and a strategic proposal for subsidiary mergers, which are both high-impact events for the company's performance and future structure. The auditor's note, while a qualification, does not overshadow the strong financial performance and strategic move.
The company reported significant year-over-year increases in both standalone and consolidated net profits for Q2 FY26. Additionally, the consideration of a merger between wholly-owned subsidiaries and the confirmation of no deviation in Rights Issue fund utilization are positive corporate developments, despite the auditor's observation on impairment.
* The Board of Directors of Coastal Corporation Limited met on 10th November 2025 and approved the Un-Audited Standalone and Consolidated Financial Results for the second quarter and half-year ended 30th September 2025. * The Board also considered a proposal to merge its two wholly-owned subsidiaries, Continental Fisheries India Limited (CFIL) and Coastal Biotech Private Limited (CBPL). * Coastal Biotech Private Limited is fully operational and has commenced selling grain-based Ethanol to Oil Marketing Companies (OMCs). * For the quarter ended 30th September 2025, the company reported: * Standalone Revenue from Operations: ₹15,395.60 lakhs. * Standalone Net Profit for the Period: ₹462.29 lakhs, with Basic EPS of ₹0.69. * Consolidated Revenue from Operations: ₹16,552.74 lakhs. * Consolidated Net Profit for the Period: ₹366.65 lakhs, with Basic EPS of ₹0.55. * The company confirmed that there was no deviation or variation in the use of funds amounting to ₹42.40 Crores raised through its Rights Issue dated 08.09.2023 for the quarter ended 30th September 2025. * The Statutory Auditors noted the non-provision of an impairment loss allowance of ₹2500.00 lakhs on the investment in M/s. Seacrest Seafoods Inc., a wholly-owned foreign subsidiary. The Board believes the investment does not suffer impairment, citing a 12-month extension for Seacrest Seafoods Inc. to buy back its shares at par. However, the Statutory Auditors declined to comment on this matter.
What to do with a filing like this
Coastal Corporation Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Coastal Corporation Limited. Read the original for the full detail.